.jpg)
Orca Bio to seek approval of T cell transplant after positive trial data
Study results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than a standard transplant in treating certain blood cancers.
Study results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than a standard transplant in treating certain blood cancers.
